The era of big pharma as product-first companies must end, as services become the larger priority.
Kostja Paschalidis
Advertisement
Articles by Kostja Paschalidis
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
How MBA Graduates Can Break into Competitive Industries in 2026: 4 Practical Steps
2
FDA Approves Otsuka’s First-In-Class Simtriyo for Adults & Pediatric Patients
3
Pharma M&A Roundup: Oak Hill Bio Combines with RACC, Apnimed Plans $150 Million IPO, CORE Biomedicine Secures $21 Million Series A
4
BioMarin and n-Lorem Foundation Enter Research Collaboration for ReNU Syndrome Treatment
5